Amir Nashat is Chief Executive Officer of Soufflé Therapeutics. Previously, he was Managing General Partner and Managing Partner at Polaris Partners, where he invested across Seed through Post-IPO Equity in Healthcare, Biotech, and RNA, primarily in the United States (including the Greater Boston Area, East Coast, and New England). He serves on the boards of CAMP4 Therapeutics, Dewpoint Therapeutics, and the Institute for Protein Innovation, and has invested in companies like Scholar Rock, AgBiome, Morphic Therapeutic, Metacrine, Inc., and Dewpoint Therapeutics. Earlier in his career, he was CEO of Dewpoint Therapeutics and Paratus Sciences, and an Entrepreneur Partner at Polaris Venture Partners. Amir holds a PhD in Chemical Engineering from MIT and an MSc in Materials Science Engineering and BSc in Mechanical Engineering from UC Berkeley. He resides in Cambridge, Massachusetts, United States.
Amir Nashat, CEO @ Soufflé Therapeutics. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Amir Nashat from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Amir
Map your path to Amir instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Amir
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.